Library

2,5-דימתוקסי-4-אתוקסי-אמפטמין

MEM, also known as 2,5-dimethoxy-4-ethoxyamphetamine or as TMA2-4-EtO, is a psychedelic drug of the phenethylamine, amphetamine, and DOx families related to TMA-2. It is the analogue of TMA-2 in which the methoxy group at the 4 position has been replaced with an ethoxy group. The drug was first described in the scientific literature by Alexander Shulgin by 1968.

Classification

  • Chemical: Amphetamine
  • Chemical: Phenethylamine
  • Psychoactive: Psychedelic
  • Psychoactive: Stimulant

Effects

  • Increased Heart Rate
  • Stimulation
  • Insomnia
  • Pupil Dilation
  • Jaw Tension
  • Talkativeness
  • Alertness Enhancement
  • Euphoria
  • Anxiety
  • Wakefulness
  • Confusion
  • Light Sensitivity
  • Color Enhancement
  • Open Eye Visuals
  • Tactile Enhancement
  • Appetite Suppression

Routes of Administration

No route information available yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

2,5-Dimethoxy-4-ethoxyamphetamine - מדריך חומרים של DrugsPRO

2,5-Dimethoxy-4-ethoxyamphetamine: MEM, also known as 2,5-dimethoxy-4-ethoxyamphetamine or as TMA2-4-EtO, is a psychedelic drug of the phenethylamine, amphetamine, and DOx families related to TMA-2. It is the analogue of TMA-2 in which the methoxy group at the 4 position has been replaced with an et

Related pages